Evidence map›Paper›PMID 33982196›Full record

ReviewThe international journal of cardiovascular imaging2021

Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.

Srilakshmi Vallabhaneni, Kathleen W Zhang, Jose A Alvarez-Cardona, Joshua D Mitchell, Henning Steen, Pamela K Woodard, Daniel J Lenihan

Abstract readReview
PubMed Publisher
In one paragraph

Review in The international journal of cardiovascular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024
    Pooled it
  2. Cancer and Heart Failure: Dangerous Liaisons.Journal of cardiovascular development and disease · 2024
    Review
  3. Review
  4. Review
  5. Editor's choice to the October 2021 issue.The international journal of cardiovascular imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Srilakshmi VallabhaneniCardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA. sriluvallabhaneni@gmail.com.ORCID http://orcid.org/0000-0002-6560-322X
Kathleen W ZhangCardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA.
Jose A Alvarez-CardonaCardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA.
Joshua D MitchellCardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA.
Henning SteenDepartment of Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
Pamela K WoodardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Daniel J LenihanCardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this review is to provide an overview of the essential role that cardiovascular magnetic resonance (CMR) has in the field of cardio-oncology. Recent findings: CMR has been increasingly used for early identification of cancer therapy related cardiac dysfunction (CTRCD) due to its precision in detecting subtle changes in cardiac function and for myocardial tissue characterization. Summary: CMR is able to identify subclinical CTRCD in patients receiving potentially cardiotoxic chemotherapy and guide initiation of cardio protective therapy. Multiparametric analysis with myocardial strain, tissue characterization play a critical role in understanding important clinical questions in cardio-oncology.

Indexed as

Antineoplastic AgentsHeart DiseasesNeoplasmsEarly Detection of CancerHumansMagnetic Resonance SpectroscopyPredictive Value of TestsAntineoplastic AgentsCancer therapy related cardiac dysfunction (CTRCD)Cardio-oncologyCMRImaging

Identifiers

PMID33982196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.